Zurück

Legal Notice (Impressum)

Provider identification pursuant to Art. 3 lit. s UCA (Switzerland)

Letzte Aktualisierung: 13.05.2026

As of 2026-05-13. Swiss law does not impose a general legal-notice duty; for electronic commerce, however, Art. 3 lit. s of the Federal Act against Unfair Competition (UCA / UWG) requires clear and complete provider identification. These details apply to the platform at mirascribe.ai and all associated subdomains.

1. Provider

MiraNext GmbH

Business address (registered seat): Innsbrucker Bundesstraße 83a, 5020 Salzburg, Austria

Service / contact address for the Swiss market: [Placeholder — where a Swiss branch or representative is appointed, with a valid address for service]

Telephone: +43 50994 9001

Email: hello@miranext.ai

2. Management and Authorised Representatives

Managing Director: DI David Baumgartner, MSc, MBA. Represents the company individually.

3. Register Entry

Commercial register number: FN 614242 y

Registry court: Regional Court of Salzburg (Landesgericht Salzburg)

Legal form: Limited liability company (GmbH) under Austrian law

Where a branch is entered in the Swiss commercial register for the Swiss market: [Placeholder — competent commercial registry office and business identification number (UID, CHE-…)].

4. Value Added Tax

VAT identification number (Austria) pursuant to § 27a UStG: ATU 78451209.

Where Swiss VAT liability applies: [Placeholder — Swiss VAT number (CHE-…MWST)].

5. Business Purpose

Development and distribution of software solutions for the healthcare sector, in particular AI-assisted applications for clinical findings documentation.

6. Supervision

MiraScribe is an AI-assisted documentation tool. The physician reviews and is responsible for all output. MiraScribe does not provide diagnosis or treatment decisions.

The authority responsible for market surveillance of therapeutic products in Switzerland: the Swiss Agency for Therapeutic Products (Swissmedic) — available at https://www.swissmedic.ch.

7. Chamber / Professional Association

MiraScribe is a software manufacturer and not itself a medical service provider; there is no mandatory membership in a Swiss medical professional body (e.g. FMH).

8. Dispute Resolution

MiraScribe is distributed exclusively to business customers and to medical doctors acting in a professional capacity. Swiss law imposes no obligation to participate in dispute resolution proceedings before a consumer arbitration board, and no such participation is foreseen.

9. Liability Notice for External Links

Despite careful review of content, no liability is assumed for the content of external links. The respective operator is solely responsible for the content of linked pages.